ArticleJMIR public health and surveillance2025
Trends in Avoidable Hospitalizations Before and During the COVID-19 Pandemic: Multiple Cross-Sectional Study Using Administrative Data From Beijing, China.
Article in JMIR public health and surveillance, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Avoidable hospitalizations (AHs) have been widely used in high-income countries as a proxy indicator for the quality of primary care. However, it is rarely evaluated in low- and middle-income countries such as China. Studies examining changes in AHs before and during the COVID-19 pandemic are also limited. The appropriateness of AHs as an indicator measuring primary care quality under pandemic conditions has not been well discussed. Objective: This study aims to describe trends in AHs in Beijing, China, during both the prepandemic (2016-2019) and pandemic (2020-2021) periods and examine factors associated with AH rates. Methods: We used hospital discharge data of Beijing residents between January 1, 2016, and December 31, 2021. We identified AH cases from all discharge cases and calculated AH rates each year, adjusting for population structure changes. We performed regression analyses to explore factors associated with AH rates, where the COVID-19 outbreak, health care resources, and socioeconomic characteristics were used as the main explanatory variables. Results: Before the COVID-19 pandemic, the total number of hospital discharges in Beijing increased steadily from 2016 to 2019 but decreased sharply in 2020 and partially rebounded in 2021. The sex- and age-standardized AH rate per 100,000 population rose from 514.7 (95% CI 511.4-517.9) in 2016 to 552.8 (95% CI 549.4-556.1) in 2019. Then it declined to 331.2 (95% CI 328.6-333.8) in 2020 and rebounded to 465.1 (95% CI 462.1-468.1) in 2021, which was still below the prepandemic level. Regression analyses show that the presence of newly confirmed COVID-19 cases was significantly associated with a lower AH rate. As for other factors, higher densities of primary physicians were linked to lower AH rates. Moreover, AH rates were also associated with population structure, the level of economic development, and demographic variables. Conclusions: The AH rate in Beijing exhibited a consistent upward trend before the pandemic and remained higher than in many high-income countries. These characteristics suggest a potential overuse of tertiary care and highlight the necessity for health care system reforms in Beijing, particularly a transition from the hospital-centered model to a primary care-focused delivery system. In addition, the observed associations between AH rates and factors, such as pandemic shock and socioeconomic variables, indicate that AH should be interpreted with appropriate controls when it is used as an indicator of primary care performance.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.